Serban Ghiorghiu
- Pulmonary and Respiratory Medicine top 0.2%
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Surgery top 10%
- Co-authors
- Suresh S. RamalingamMyung‐Ju AhnHelen MannFrances A. ShepherdChee Khoon LeeTony MokYi‐Long WuAlison Templeton
- Topics
- Lung Cancer Treatments and Mutations (24 papers)Lung Cancer Research Studies (10 papers)Colorectal Cancer Treatments and Studies (6 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Serban Ghiorghiu
29 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pulmonary and Respiratory Medicine 5.1k
- Oncology 4.0k
- Molecular Biology 1.8k
- Cancer Research 1.4k
- Surgery 297
Countries citing papers authored by Serban Ghiorghiu
This map shows the geographic impact of Serban Ghiorghiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serban Ghiorghiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serban Ghiorghiu more than expected).
Fields of papers citing papers by Serban Ghiorghiu
This network shows the impact of papers produced by Serban Ghiorghiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serban Ghiorghiu. The network helps show where Serban Ghiorghiu may publish in the future.
Co-authorship network of co-authors of Serban Ghiorghiu
This figure shows the co-authorship network connecting the top 25 collaborators of Serban Ghiorghiu. A scholar is included among the top collaborators of Serban Ghiorghiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serban Ghiorghiu. Serban Ghiorghiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 8 | |
| 4 | Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer | 290 |
| 5 | 1 | |
| 6 | 2 | |
| 7 | Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancerbreakdown → | 2369 |
| 8 | Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 studybreakdown → | 502 |
| 9 | 15 | |
| 10 | 7 | |
| 11 | AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancerbreakdown → | 1585 |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 104 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | 7 | |
| 18 | 267 | |
| 19 | A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck | 18 |
| 20 | 12 |
About Serban Ghiorghiu
Serban Ghiorghiu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 30 papers that have together received 5.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (10 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.1k citations), Oncology (4.0k citations) and Cancer Research (1.4k citations). Serban Ghiorghiu has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Suresh S. Ramalingam, Myung‐Ju Ahn, Helen Mann, Frances A. Shepherd, Chee Khoon Lee, Tony Mok, Yi‐Long Wu, Alison Templeton, Vassiliki A. Papadimitrakopoulou and Willemijn S.M.E. Theelen. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.